Bupivacaine Injection
DrugBucivacaine will be administered intramuscularly according to package insert directions after first numbing the area with lidocaine subcutaneously
Other names: Bupivacaine Hydrochloride Injection
NCT Number: NCT05794828
Interventional study to use erector spinae plane block (ESPB) on diagnoses of posterior or lateral rib fractures, vertebral fractures, pancreatitis, pancreatic cancer, renal colic, and back pain for multimodal pain therapy to determine its assistance with pain relief as well as the patient's use of opiates after block completion
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Early Phase 1
Crozer Chester Medical Center, Ridley Park, Pennsylvania, United States
Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance. They will rate their pain before and 30 minutes after the procedure using the ordinal categorical data on a numeric pain scale. Total patient opiate use will be gathered up to 8 hours after block completion.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bucivacaine will be administered intramuscularly according to package insert directions after first numbing the area with lidocaine subcutaneously
Other names: Bupivacaine Hydrochloride Injection
Time frame: Baseline to study procedure end (approximately 30 minutes)
Change in pain scale rating assessed by the participants on a scale from 0-10 with 0 indicating no pain and 10 indicating the most severe pain.
The University of Texas Health Science Center at San Antonio
Other
Erector Spinae Regional Anesthesia for Pain Control in the Emergency Department
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04401007
Agnosia, Nervous System Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT07736118
Agnosia, Behavior
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT06811701
Agnosia, Craniotomy Surgery
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07722221
Agnosia, Dental Anxiety
Latakia, Syria
View Trial Details